Gene: CHD1
Official Full Name: chromodomain helicase DNA binding protein 1provided by HGNC
Gene Summary: The CHD family of proteins is characterized by the presence of chromo (chromatin organization modifier) domains and SNF2-related helicase/ATPase domains. CHD genes alter gene expression possibly by modification of chromatin structure thus altering access of the transcriptional apparatus to its chromosomal DNA template. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO03567 | CHD1 Knockout cell line (HeLa) | Human | CHD1 | 1:3~1:6 | Negative | Online Inquiry |
KO03568 | CHD1 Knockout cell line (HCT 116) | Human | CHD1 | 1:2~1:4 | Negative | Online Inquiry |
KO03569 | CHD1 Knockout cell line (HEK293) | Human | CHD1 | 1:3~1:6 | Negative | Online Inquiry |
KO03570 | CHD1 Knockout cell line (A549) | Human | CHD1 | 1:3~1:4 | Negative | Online Inquiry |
CHD1 Gene Knockout Cell Lines are genetically modified cell lines specifically designed to facilitate the study of the chromodomain-helicase-DNA-binding protein 1 (CHD1). This protein plays an essential role in chromatin remodeling, a critical process for regulating gene expression and maintaining genomic integrity. Through precise gene editing techniques, these knockout cell lines effectively disable the CHD1 gene, enabling researchers to investigate the functional implications of CHD1 deficiency on cellular processes and pathways.
The main function of CHD1 is to facilitate the dynamic alteration of chromatin structure, allowing for the accessibility of transcriptional machinery to DNA. By utilizing these knockout cell lines, scientists can elucidate the downstream effects of CHD1 loss on gene expression profiles, DNA repair mechanisms, and overall cellular behavior. This detailed understanding is crucial in advancing the knowledge surrounding various pathologies, including cancer and developmental disorders, where chromatin dysregulation is often implicated.
The scientific importance of CHD1 Gene Knockout Cell Lines lies in their versatile applicability in both basic and translational research. They provide a model system to explore the therapeutic potential of targeting chromatin remodeling pathways and could aid in the development of novel treatment strategies aimed at restoring normal gene function or inhibiting tumor progression.
Compared to alternative models, such as transient knockdown approaches, the CHD1 Gene Knockout Cell Lines offer a stable and consistent platform for long-term studies. This stability allows for repeated experimental assays and robust data generation, yielding more reliable and reproducible results over time. Additionally, these cell lines can be easily integrated into high-throughput screening processes, expanding their utility in pharmacological research.
For researchers and clinicians focused on the underlying mechanisms of gene regulation and chromatin dynamics, the value of CHD1 Gene Knockout Cell Lines is undeniable. They provide a unique opportunity to dissect the role of CHD1 in a controlled environment while generating insights that could have far-reaching implications for human health and disease management.
Our company prides itself on offering cutting-edge biological products backed by rigorous scientific validation, ensuring that our customers have access to tools that can transform their research into impactful discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.